SUVENPHAR: Members of the Exchange are hereby informed that the name of Suven Pharmaceuticals Limited shall be changed to Cohance Lifesciences Limited and symbol be changed to COHANCE w.e.f. May 19, 2025.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has announced that Suven Pharmaceuticals Limited will be renamed Cohance Lifesciences Limited, effective May 19, 2025. The trading symbol will change from SUVENPHAR to COHANCE on the same date. The company is undergoing a rebranding, likely reflecting its expanded business focus beyond traditional pharmaceuticals into broader life sciences offerings. Existing shareholders continue to hold the same number of shares with no change in ownership structure. Investors and brokers need to update their records and trading systems to reflect the new name and symbol.
This is a cosmetic change with no impact on shareholding, financial position, or stock price. Investors should update their watchlists and trading platforms to use the new symbol COHANCE from May 19, 2025.